07 Jan 2001

Doneurin® 10 (Doneurin® 10/-25/-50/-75/-100/-150 Kapseln) - Deutschland

Updated: 07 Jan 2001

Doneurin® 10 | -25 | -50 | -75 | -100 | -150; -50 | -100 Filmtabletten

Depressive Syndr. Angstsyndr. Unruhe, Angst, Schlafstör. funkt. Organbeschw. leichte Entzugssyndr. b. Alkohol-, Medikamenten- od. Drogenabhängigk. Doneurin 150: Behandl. v. depress. Erkrank. u. Angstsyndr. im Rahmen e. station. Gesamtkonzeptes.

Doneurin® 10 Description, Presentation and Dosage

Doneurin® 10 Description

Doneurin® 10 Drug Class Description

Einzelstoffe

Doneurin® 10 Drug Description

1 Kps. enth.: Doxepin-HCl 11,31 mg/28,26 mg/56,52 mg/84,79 mg/113,05 mg/169,57 mg (entspr. 10 mg/25 mg/50 mg/75 mg/100 mg/150 mg Doxepin).

Doneurin® 10 Generic Name

Doneurin® 10/-25/-50/-75/-100/-150 Kapseln

Doneurin® 10 Presentation

Doneurin® 10 Presentation

Doneurin® 10/-25/-50/-75/-100/-150; -50/-100 Filmtabletten

Doneurin® 10 Manufacturer

Hexal/Neuro Hexal

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Doneurin® 10 Dosage

Doneurin® 10 Adult Dosage

Cellulose, Gelatine, Magnesiumstearat, Natriumdodecylsulfat, Quellstärke, Siliciumdioxid, zusätzl.: Doneurin 10/-150: Farbstoffe E 132, E 171, Doneurin 25: Farbstoffe E 104, E 171, E 172, Doneurin 50: Farbstoffe E 122, E 127, E 132, E 171, Doneurin 75: Farbstoffe E 171, E 172, Doneurin 100: Farbstoffe E 171, E 172.

Doneurin® 10 Child Dosage


Doneurin® 50/-100 Filmtabletten
Zus.: 1 Filmtbl. enth.: Doxepin-HCl 53,84 mg/113,06 mg (entspr. 50 mg/100 mg Doxepin).
Weit. Bestandteile: Carboxymethylstärke-Na, Cellulose, Copolyvidon, Lactose, Macrogol 400, Mg-stearat, Hypromellose, Farbstoff E 171.

Doneurin® 10 Precautions, Reactions and Contraindications

Doneurin® 10 Special Precautions

Doneurin® 10 Special Precautions

D 75

Doneurin® 10 Adverse Reactions

Doneurin® 10 Adverse Reactions

D 75. Strenge Ind.-Stellung vor allem im 3. Trim.

Related Drugs - Psychiatry/Mental Health

Back to top